Arno Therapeutics, Inc.
ARNI
$0.0001
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | 09/30/2015 | |
|---|---|---|---|---|---|
| Net Income | -3.85M | -2.14M | -3.71M | -4.00M | -679.30K |
| Total Depreciation and Amortization | 1.80K | 1.80K | 1.80K | 1.80K | 1.80K |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 10.10K | 2.40K | -- |
| Total Other Non-Cash Items | 3.04M | -104.70K | 1.81M | 1.88M | -1.26M |
| Change in Net Operating Assets | -329.10K | 565.60K | -764.10K | -32.90K | -301.70K |
| Cash from Operations | -1.14M | -1.68M | -2.65M | -2.14M | -2.24M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 1.60K |
| Total Debt Issued | -- | -- | -- | 2.10M | -- |
| Total Debt Repaid | -1.00K | -900.00 | -900.00 | -900.00 | -800.00 |
| Issuance of Common Stock | 2.35M | 0.00 | 5.28M | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -22.40K | -65.80K | -2.50K | -12.50K | -- |
| Cash from Financing | 2.33M | -66.70K | 5.27M | 2.09M | -800.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.19M | -1.75M | 2.62M | -56.30K | -2.24M |